Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Single infusion of low-dose ofatumumab in a child with complicated nephrotic syndrome with anti-rituximab antibodies.

Literature DB >> 29247358

Single infusion of low-dose ofatumumab in a child with complicated nephrotic syndrome with anti-rituximab antibodies.

Shuichiro Fujinaga¹, Koji Sakuraya^2,3.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2017 PMID： 29247358 DOI： 10.1007/s00467-017-3866-2

Source DB: PubMed Journal: Pediatr Nephrol ISSN： 0931-041X Impact factor: 3.714

× No keyword cloud information.

3 in total

1. Ofatumumab for the treatment of childhood nephrotic syndrome.

Authors: Chia-Shi Wang; Rochelle Schmidt Liverman; Rouba Garro; Roshan Punnoose George; Anastacia Glumova; Alana Karp; Stephanie Jernigan; Barry Warshaw
Journal: Pediatr Nephrol Date: 2017-02-17 Impact factor: 3.714

2. Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab.

Authors: Marina Vivarelli; Manuela Colucci; Alice Bonanni; Martina Verzani; Jessica Serafinelli; Francesco Emma; Gianmarco Ghiggeri
Journal: Pediatr Nephrol Date: 2016-09-29 Impact factor: 3.714

3. Development of antirituximab antibodies in children with nephrotic syndrome.

Authors: Yo Han Ahn; Hee Gyung Kang; Jiwon M Lee; Hyun Jin Choi; Il-Soo Ha; Hae Il Cheong
Journal: Pediatr Nephrol Date: 2014-03-12 Impact factor: 3.714

3 in total

6 in total

1. Is cytokine-release syndrome the cause of rituximab treatment-related infusion reactions in children with nephrotic syndrome? Impact of anti-rituximab antibodies.

Authors: Shuichiro Fujinaga; Tomohiko Nishino
Journal: Pediatr Nephrol Date: 2018-04-19 Impact factor: 3.714

Single infusion of low-dose ofatumumab in a child with complicated nephrotic syndrome with anti-rituximab antibodies.

1. Ofatumumab for the treatment of childhood nephrotic syndrome.

2. Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab.

3. Development of antirituximab antibodies in children with nephrotic syndrome.

1. Is cytokine-release syndrome the cause of rituximab treatment-related infusion reactions in children with nephrotic syndrome? Impact of anti-rituximab antibodies.

2. Rituximab-induced serum sickness in a 6-year-old boy with steroid-dependent nephrotic syndrome.

3. Ofatumumab rescue treatment in post-transplant recurrence of focal segmental glomerulosclerosis.

4. Ofatumumab for multirelapsing membranous nephropathy complicated by rituximab-induced serum-sickness.

5. UK experience of ofatumumab in recurrence of focal segmental glomerulosclerosis post-kidney transplant.

Review 6. Current understandings in treating children with steroid-resistant nephrotic syndrome.